Embody vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

Shed beats Embody overall, scoring 7.8/10 vs 7.3/10. Shed is more affordable at $199/mo vs $299/mo. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of Embody and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

Embody

#31 of 40
7.3/10

Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.

Visit Embody
Higher Rated

Shed

#16 of 40
7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed
FeatureEmbodyShed
Our Score7.3/107.8/10
Starting Price$299/mo$199/mo
Medication TypeCompoundedCompounded
Insurance AcceptedNoNo
Best ForUsers looking for the lowest entry price with round-the-clock specialist supportUsers who want fast delivery and a streamlined compounded GLP-1 experience
Ranking#31#16

Pros & Cons Compared

Embody

Pros

  • +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
  • +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
  • +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
  • +Personalized metabolic report helps you understand your body's baseline before starting treatment

Cons

  • Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
  • Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
  • Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed

Shed

Pros

  • +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
  • +$149/mo is competitively priced for an all-inclusive compounded program with good support
  • +Streamlined onboarding with no video call — approved and shipped faster than most competitors
  • +Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

  • Compounded semaglutide and tirzepatide only — no brand-name options
  • Newer company (founded 2024) with limited track record and outcome data
  • No insurance billing and no FSA/HSA superbills currently available
  • Clinical support is responsive but less proactive than premium platforms

Our Verdict

Shed edges out Embody with a score of 7.8/10 vs 7.3/10. If budget is your priority, Shed starts at $199/mo compared to Embody's $299/mo. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Try Embody

Starting at $299/mo

Visit Embody

Try Shed

Starting at $199/mo

Visit Shed